GOLDMAN SACHS GROUP INC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 23 filers reported holding XENON PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$14,199,105
+10.0%
364,173
+21.5%
0.00%0.0%
Q1 2024$12,905,271
-25.5%
299,774
-20.3%
0.00%
-33.3%
Q4 2023$17,332,470
+98.7%
376,302
+47.4%
0.00%
+50.0%
Q3 2023$8,723,371
-17.6%
255,368
-7.2%
0.00%0.0%
Q2 2023$10,590,580
+3.7%
275,080
-3.6%
0.00%0.0%
Q1 2023$10,215,289
-8.6%
285,423
+0.7%
0.00%
-33.3%
Q4 2022$11,180,022
+66463.6%
283,541
-39.1%
0.00%
-25.0%
Q3 2022$16,796
+86.3%
465,265
+57.0%
0.00%
+100.0%
Q2 2022$9,014
-100.0%
296,314
-59.1%
0.00%
-60.0%
Q1 2022$22,143,000
+313.6%
724,337
+322.6%
0.01%
+400.0%
Q4 2021$5,354,000
+265.0%
171,394
+78.6%
0.00%
Q3 2021$1,467,000
-48.2%
95,985
-36.9%
0.00%
-100.0%
Q2 2021$2,834,000
+17.1%
152,218
+12.6%
0.00%0.0%
Q1 2021$2,420,000
+14.0%
135,219
-2.0%
0.00%0.0%
Q4 2020$2,122,000
+209.3%
137,961
+122.6%
0.00%
Q3 2020$686,000
+86.9%
61,966
+111.7%
0.00%
Q2 2020$367,000
+115.9%
29,272
+126.3%
0.00%
Q4 2019$170,000
+78.9%
12,937
+22.9%
0.00%
Q3 2019$95,000
-23.4%
10,529
-14.0%
0.00%
Q1 2019$124,000
+55.0%
12,246
-3.3%
0.00%
Q4 2018$80,000
-60.4%
12,663
+5.5%
0.00%
Q1 2015$202,000
-50.9%
11,999
-42.3%
0.00%
Q4 2014$411,00020,8000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
BVF INC/IL 3,516,851$44,101,0002.72%
Parkman Healthcare Partners LLC 590,267$7,402,0002.08%
ACUTA CAPITAL PARTNERS, LLC 517,500$6,489,0001.88%
Soleus Capital Management, L.P. 250,897$3,146,0001.79%
DAFNA Capital Management LLC 346,535$4,346,0001.25%
KNOTT DAVID M 169,000$2,119,0001.16%
Ghost Tree Capital, LLC 325,000$4,076,0001.08%
Avoro Capital Advisors LLC 2,800,000$35,112,0000.69%
NEA Management Company, LLC 992,107$12,441,0000.50%
Orbimed Advisors 2,497,917$31,324,0000.44%
View complete list of XENON PHARMACEUTICALS INC shareholders